Further, to better understand the underlying mechanisms of action of progesterone, we performed whole transcriptome sequencing of T47-D (PR + /ER + /Her2-) and MDA-MB-231 (PR-/ER-/Her2-) breast cancer cells in response to progesterone treatment. This evidence concerns the gene ERBB2 and breast carcinoma.